Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2005
06/30/2005CA2548572A1 Hydroxylamine derivatives
06/30/2005CA2547820A1 (s)-2-n-propylamino-5-hydroxytetralin as a d3 agonist
06/30/2005CA2547804A1 Novel thiazole derivatives
06/30/2005CA2547764A1 Benzoxazine derivatives and uses thereof
06/30/2005CA2547195A1 Microemulsion preconcentrate comprising a renin inhibitor
06/30/2005CA2546979A1 A biological active blood serum, methods of producing it and uses thereof
06/30/2005CA2545506A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
06/30/2005CA2545503A1 Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases
06/29/2005EP1548025A2 Sapogenin derivatives and their use in the treatment of cognitive dysfunction
06/29/2005EP1547650A1 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
06/29/2005EP1547606A1 Method of preparing platelet rich plasma
06/29/2005EP1547600A1 Female hormone-containing patch
06/29/2005EP1547597A2 Use of adatanserin for the treatment of neurodegenerative conditions
06/29/2005EP1547592A1 Intranasal formulation of rotigotine
06/29/2005EP1546377A2 Methods and compositions to treat pain and painful disorders using 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002,16209, 314, 636, 27410, 33260, 619,15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 or 13424 molecules
06/29/2005EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
06/29/2005EP1546156A1 3-(carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors
06/29/2005EP1546151A1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
06/29/2005EP1546147A1 Morpholine-bridged indazole derivatives
06/29/2005EP1546146A1 POLYMORPHIC FORMS OF ZIPRASIDONE HCl AND PROCESSES FOR THEIR PREPARATION
06/29/2005EP1546145A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
06/29/2005EP1546143A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
06/29/2005EP1546134A1 Piperazine substituted aryl benzodiazepines
06/29/2005EP1546123A1 Benzyl morpholine derivatives
06/29/2005EP1546120A2 Pharmaceutical compositions for treatment of parkinson's disease
06/29/2005EP1546117A2 Protein kinase inhibitors and uses thereof
06/29/2005EP1546115A2 Substituted pyrimidines
06/29/2005EP1546103A1 Piperazine and piperidine derivatives for treatment of neurological diseases
06/29/2005EP1546101A1 Naphthyl ether compounds and their use
06/29/2005EP1546100A1 New benzoyl piperidine compounds
06/29/2005EP1546084A1 2,4-dihydroxybenzoic acid derivatives
06/29/2005EP1545710A2 Therapeutic use
06/29/2005EP1545618A1 Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
06/29/2005EP1545552A1 Combination therapy wherein a serotonin reuptake inhibitor is used
06/29/2005EP1545546A1 Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines
06/29/2005EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives
06/29/2005EP1545537A1 Alpha-7 nicotinic receptor agonists and statins in combination
06/29/2005EP1545531A1 Use of 5-ht2 receptor antagonists for the treatment of sleep disorders
06/29/2005EP1545513A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
06/29/2005EP1545511A1 Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
06/29/2005EP1545491A1 Therapeutic use of fused bicyclic or tricyclic amino acids
06/29/2005EP1545489A1 Treatment of depression secondary to pain (dsp)
06/29/2005EP1545488A1 Choline ascorbate formulations
06/29/2005EP1545487A1 Use of a sri and vitamin b6 for the treatment of neurological and mental disorders
06/29/2005EP1545486A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome
06/29/2005EP1545485A2 Treatment of cns disorders with trans-4- (3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine
06/29/2005EP1485352B1 Azaspiro compounds for the treatment of pain
06/29/2005EP1432686B1 Tetrahydroisochinolines, their production and the use thereof as analgesics
06/29/2005EP1408943B1 Pharmaceutical formulation containing an ltb4 antagonist and a wetting agent
06/29/2005EP1395550B1 Cycloalkenylsulfonamide derivatives
06/29/2005EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives
06/29/2005EP1315727B1 7-oxo pyridopyrimidines
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005EP1246624B1 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
06/29/2005EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
06/29/2005EP1225951B1 A dual adhesive transdermal drug delivery system
06/29/2005EP1152762B8 Use of desoxypeganine in the treatment of alzheimer's dementia
06/29/2005EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha
06/29/2005EP0929574B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS
06/29/2005EP0735888B1 Purine compositions
06/29/2005CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof
06/29/2005CN1633440A Derivatives of branched-chain lipophilic molecules and uses thereof
06/29/2005CN1633436A Pyrrolopyrimidine derivatives
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633430A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
06/29/2005CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2005CN1633421A Oxazole/thiazol-derivatives activators of the hppar-alpha receptor
06/29/2005CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/29/2005CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity
06/29/2005CN1633416A Nicotinamide derivates useful as p38 inhibitors
06/29/2005CN1633414A Chemical compounds
06/29/2005CN1633308A Treatment of ophthalmic disorders using urea and urea derivatives
06/29/2005CN1633301A Extracts from sophora, production method and purposes thereof
06/29/2005CN1633299A Estrogen replacement therapy
06/29/2005CN1633298A Novel use of 2-phenyl-substituted imidazotriazinones
06/29/2005CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists
06/29/2005CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2005CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
06/29/2005CN1633292A Cotherapy with an oxazolidinone and a vitamin B
06/29/2005CN1633291A 2-oxazolamines and their use as 5-ht2b receptor antagonists
06/29/2005CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
06/29/2005CN1633288A Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
06/29/2005CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
06/29/2005CN1633283A Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
06/29/2005CN1633282A Orodispersible effervescent tablets
06/29/2005CN1631865A Compounds with anti neurocyte apoptosis function
06/29/2005CN1631408A Chinese medicinal composite formulation for treating wind blood stasis syndrome of head wind disease
06/29/2005CN1631399A Decoction for treating headache
06/29/2005CN1631368A Sustained release formulation containing effective active component of galanthamin and its preparation process
06/29/2005CN1631360A Freeze dried injection of lysine hydrochloride and its preparation process
06/29/2005CN1208375C Powdered rubber powder containing modified filler, its preparing method and its use
06/29/2005CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives
06/29/2005CN1208333C Indole derivatives useful for the treatment of osteoporosis
06/29/2005CN1208323C Alpha-substituted carboxylic acid derivatives
06/29/2005CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
06/29/2005CN1208081C Medicine for stopping smoking and preparing process thereof
06/29/2005CN1208080C Application of capsule of schisandra fruit for preparing medicine for treating sleep disorder
06/29/2005CN1208064C Hyperhydrated citicoline, process and use
06/29/2005CN1208054C Sustained releasing huperzine preparation
1 ... 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 ... 1833